基本信息
浏览量:82
职业迁徙
个人简介
Joost de Bruijn, PhD, FBSE is a serial entrepreneur with more than 25yrs experience in academia and industry. Joost is Chief Executive Officer of Kuros Biosciences AG (SIX: KURN) since 2017 and has completed several successful business deals and raised over $50m in equity financing in the past 3 years. As serial entrepreneur, Joost founded Xpand Biotechnology BV in 2014 (acquired by Kuros Biosciences AG in 2017), Progentix Orthobiology BV (sold to NuVasive Inc. in 2018) and Scinus Cell Expansion BV.
研究兴趣
论文共 215 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Wei Lei,Yan Wu, Ping He, Jingqi Wu, Jingrong Chen, Yuxiao Liu,Hongmei Zhang,Joost de Bruijn,Chongyun Bao, Yong Li,Ping Ji,Huipin Yuan,
crossref(2024)
Clinical cancer research : an official journal of the American Association for Cancer Researchno. 20 (2023): 4219-4229
引用0浏览0WOS引用
0
0
Biomaterials (2023): 122356-122356
引用0浏览0WOS引用
0
0
Jort J. van der Schans, Ziyu Wang,Jennemiek van Arkel,Thijs van Schaik, Afroditi Katsarou,Ruud Ruiter, Thomas Baardemans,Huipin Yuan,Joost de Bruijn,Sonja Zweegman,Niels W. C. J. van de Donk,Richard W. J. Groen,
CLINICAL CANCER RESEARCHno. 20 (2023): 4219-4229
Journal of Immunology and Regenerative Medicine (2023): 100070-100070
Jiaxian Wang, Thomas Baardemans,Ricardo de Matos Simoes,Olga Dashevsky,Huipin Yuan,Joost D. de Bruijn,Anton C. Martens,Constantine S. Mitsiades,Richard W. Groen
CANCER RESEARCHno. 12 (2022)
引用0浏览0引用
0
0
Ruggero Belluomo, Inazio Arriola-Alvarez,Nathan W Kucko,William R Walsh,Joost D de Bruijn,Rema A Oliver, Dan Wills,James Crowley,Tian Wang,Florence Barrère-de Groot
Acta biomaterialia (2022): 625-638
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn